Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06364904
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-04-10
Brief Title:
An Phase III Study MulticenterRandomized Controlled Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-04-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-04-15
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-10
First Submit QC Date:
April 10 2024
Study First Post Date:
2024-04-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-10
Last Update Post Date:
2024-04-15
Last Update Post Date Type:
ACTUAL